A 2023 Lancet study reveals 15-20% of type 2 diabetes patients exhibit autoimmune markers, with new ADA guidelines advocating combined GADA/ICA/IAA testing to prevent diagnostic delays and improve out...
New ADA guidelines and wearable tech integrations are revolutionizing resistance training’s role in glucose control and sarcopenia prevention for 96 million US prediabetic adults. 2023 ADA stand...
New research shows combined GADA, ICA, and IAA testing identifies 10% of type 2 diabetes cases as LADA, with significant treatment implications. Groundbreaking studies reveal that comprehensive autoan...
Discover how AI-driven meal planning and personalized nutrition are revolutionizing diabetes care, backed by the latest ADA guidelines and cutting-edge research. New research and AI tools are reshapin...
Exploring circadian rhythm science in glucose metabolism, this article provides evidence-based eating schedules and meal plans for diabetics, aligned with natural insulin sensitivity fluctuations. Dis...